Editorial: Lipidomics of oxylipins in biological systems.
作者信息
Patrignani Paola, Schebb Nils Helge, Werz Oliver, Steinhilber Dieter
机构信息
Paola Patrignani, "G. d'Annunzio" University, Chieti, Italy.
Nils Helge Schebb, University of Wuppertal, Wuppertal, Germany.
出版信息
Front Pharmacol. 2023 Dec 6;14:1342596. doi: 10.3389/fphar.2023.1342596. eCollection 2023.
Abstract
摘要
相似文献
1
Editorial: Lipidomics of oxylipins in biological systems.
Front Pharmacol. 2023 Dec 6;14:1342596. doi: 10.3389/fphar.2023.1342596. eCollection 2023.
2
Changes in bioactive lipid mediators in response to short-term exposure to ambient air particulate matter: A targeted lipidomic analysis of oxylipin signaling pathways.
Environ Int. 2021 Feb;147:106314. doi: 10.1016/j.envint.2020.106314. Epub 2020 Dec 14.
3
Synthesis and function of fatty acids and oxylipins, with a focus on Caenorhabditis elegans.
Prostaglandins Other Lipid Mediat. 2020 Jun;148:106426. doi: 10.1016/j.prostaglandins.2020.106426. Epub 2020 Feb 4.
4
Oxidation of polyunsaturated fatty acids to produce lipid mediators.
Essays Biochem. 2020 Sep 23;64(3):401-421. doi: 10.1042/EBC20190082.
5
The octadecanoids: an emerging class of lipid mediators.
Biochem Soc Trans. 2022 Dec 16;50(6):1569-1582. doi: 10.1042/BST20210644.
6
A Lipidomics- and Transcriptomics-Based Analysis of the Intestine of Genetically Obese () and Diabetic () Mice: Links with Inflammation and Gut Microbiota.
Cells. 2023 Jan 25;12(3):411. doi: 10.3390/cells12030411.
7
Production of eicosanoids and other oxylipins by pathogenic eukaryotic microbes.
Clin Microbiol Rev. 2003 Jul;16(3):517-33. doi: 10.1128/CMR.16.3.517-533.2003.
8
Polyunsaturated fatty acids and fatty acid-derived lipid mediators: Recent advances in the understanding of their biosynthesis, structures, and functions.
Prog Lipid Res. 2022 Apr;86:101165. doi: 10.1016/j.plipres.2022.101165. Epub 2022 May 1.
9
Elevated levels of pro-inflammatory oxylipins in older subjects are normalized by flaxseed consumption.
Exp Gerontol. 2014 Nov;59:51-7. doi: 10.1016/j.exger.2014.04.005. Epub 2014 Apr 18.
10
Harmonized procedures lead to comparable quantification of total oxylipins across laboratories.
J Lipid Res. 2020 Nov;61(11):1424-1436. doi: 10.1194/jlr.RA120000991. Epub 2020 Aug 26.
本文引用的文献
1
Failure to apply standard limit-of-detection or limit-of-quantitation criteria to specialized pro-resolving mediator analysis incorrectly characterizes their presence in biological samples.
Nat Commun. 2023 Nov 9;14(1):7172. doi: 10.1038/s41467-023-41766-w.
2
Formation, Signaling and Occurrence of Specialized Pro-Resolving Lipid Mediators-What is the Evidence so far?
Front Pharmacol. 2022 Mar 2;13:838782. doi: 10.3389/fphar.2022.838782. eCollection 2022.
3
On the biosynthesis of specialized pro-resolving mediators in human neutrophils and the influence of cell integrity.
Biochim Biophys Acta Mol Cell Biol Lipids. 2022 Mar;1867(3):159093. doi: 10.1016/j.bbalip.2021.159093. Epub 2021 Dec 21.
4
Cyclooxygenase inhibitors: From pharmacology to clinical read-outs.
Biochim Biophys Acta. 2015 Apr;1851(4):422-32. doi: 10.1016/j.bbalip.2014.09.016. Epub 2014 Sep 28.
5
Characterization of a human and murine mPGES-1 inhibitor and comparison to mPGES-1 genetic deletion in mouse models of inflammation.
Prostaglandins Other Lipid Mediat. 2013 Dec;107:26-34. doi: 10.1016/j.prostaglandins.2013.09.001. Epub 2013 Sep 14.
6
Asymmetric acetylation of the cyclooxygenase-2 homodimer by aspirin and its effects on the oxygenation of arachidonic, eicosapentaenoic, and docosahexaenoic acids.
Mol Pharmacol. 2010 Jun;77(6):979-86. doi: 10.1124/mol.109.063115. Epub 2010 Mar 1.
Zotero 插件